Stereotaxis (STXS) News
Filter STXS News Items
STXS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest STXS News From Around the Web
Below are the latest news stories about STEREOTAXIS INC that investors may wish to consider to help them evaluate STXS as an investment opportunity.
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease PatientsLEXINGTON, Ky. and ST. LOUIS, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, and Baptist Health Lexington, a leading health provider in Kentucky, today announced that physicians have built upon their two-decades of leadership in robotic heart care with the successful treatment of first patients using the newest advancement in the technology, the Genesis Robotic Magnetic Navigation (RMN) System. Electrop |
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare ConferenceST. LOUIS, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Piper Sandler 35th Annual Healthcare Conference. Mr. Fischel will present on Stereotaxis’ business and technology during a Fireside Discussion on Thursday, November 30, 2023, at 1:30 pm ET. Mr. Fischel will be available for one-on-one meetings that sam |
Stereotaxis, Inc. (AMEX:STXS) Q3 2023 Earnings Call TranscriptStereotaxis, Inc. (AMEX:STXS) Q3 2023 Earnings Call Transcript November 9, 2023 Stereotaxis, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.05. Operator: Good morning. Thank you for joining us for Stereotaxis’ Third Quarter 2023 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to follow may relate to […] |
Q3 2023 Stereotaxis Inc Earnings CallQ3 2023 Stereotaxis Inc Earnings Call |
Stereotaxis Inc (STXS) Reports Modest Revenue Growth in Q3 2023 Amid Strategic AdvancesFinancial Discipline and Innovation Strategy Drive Third Quarter Results |
Stereotaxis Reports 2023 Third Quarter Financial ResultsST. LOUIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2023. “Stereotaxis continues to deliver commercial results and advance a robust innovation strategy, while maintaining financial discipline,” said David Fischel, Chairman and CEO. “Revenue growth in the quarter was driven by continued demand for Genesis w |
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United StatesST. LOUIS, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the United States have been treated successfully utilizing Abbott’s EnSite™ X EP System integrated with Stereotaxis’ Robotic Magnetic Navigation System. The integration of Abbott’s leading cardiac mapping system and Stereotaxis’ advanced robotic technology, first announced at Heart Rhythm 20 |
Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 third quarter on Thursday, November 9, 2023 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments. What:Stereotaxis third quarter 202 |
Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic NavigationST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will participate in the Society for Cardiac Robotic Navigation’s 7th Annual Meeting, which will take place October 19-20 in Washington, DC. The global physician-led Society for Cardiac Robotic Navigation (SCRN) is dedicated to establishing a community and platform for users of robotic technologies in card |
AxoGen (AXGN) Moves 6.8% Higher: Will This Strength Last?AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. |